Prohibition

Clinton Explains Position On Marijuana Policy

Over the weekend, Hilary Clinton expanded on her position regarding marijuana policy reform. Specifically, she stated that she would like to see marijuana rescheduled.

Huffington Post reports:

[caption id="attachment_9348" align="alignright" width="200"]Hillary_Clinton_official_Secretary_of_State_portrait_crop Hillary Clinton[/caption]

Hillary Clinton wants to reclassify marijuana as a less dangerous substance in order to allow more research into the drug's medicinal properties, the Democratic presidential candidate said Saturday in South Carolina.

Marijuana is currently classified as a Schedule I drug, the most dangerous of five substance categories listed in the Controlled Substances Act. According to the federal classification, Schedule I drugs have "no currently accepted medical use." Other Schedule I substances include heroin, ecstasy and LSD. 

Under Clinton's proposal, marijuana would become a Schedule II substance, which are considered to have "less abuse potential." Cocaine, OxyContin, Adderall and meth are Schedule II drugs. The move, Clinton said Saturday, would allow federal researchers to explore how to best use marijuana as medicine.

"What I do want is for us to support research into medical marijuana because a lot more states have passed medical marijuana than have legalized marijuana, so we've got two different experiences or even experiments going on right now," Clinton said after being asked about marijuana prohibition during a town hall. "And the problem with medical marijuana is there's a lot of anecdotal evidence about how well it works for certain conditions, but we haven't done any research. Why? Because it's considered what's called a Schedule I drug and you can't even do research in it." 

"If we're going to have a lot of states setting up marijuana dispensaries so that people who have some kind of medical need are getting marijuana, we need know what's the quality of it, how much should you take, what should you avoid if you're taking other medications," she continued. 

Clinton has said previously that she does not support legalizing marijuana, but believes in the medical use of cannabis and reforming the criminal justice system to keep low-level drug offenders out of jail. 

 

Read more

Medical Marijuana||Research

Iowa Board of Pharmacy Delays Decision on the Reclassification of Medical Marijuana

After some members expressed reservations, the Iowa Pharmacy Board decided on Wednesday to delay its decision on marijuana’s drug classification until January.

A board subcommittee initially recommended that the entire board consider reclassifying the substance from a Schedule I drug to a Schedule II drug. The recommendation was based on marijuana’s use for medical purposes, bolstered by a new law in Iowa that made the use of CBD oil, which is derived from the marijuana plant, legal for the treatment of children with epilepsy.

An Iowa Pharmacy Board member and pharmacist from Monona, Edward Maier, read the subcommittee’s recommendation:

“While the board believes that marijuana has a high potential for abuse, in 2014 the Iowa General Assembly passed the Medical Cannabinoid Act. The act permits the use of cannanbidiol for patients suffering from intractable epilepsy. The passage of this act is an affirmative recognition by the Iowa General Assembly that there is a medical use for marijuana. Continued placement for marijuana in Schedule I is not consistent with that act,” Maier said, reading directly from the recommendation.

Maier also emphasized that even if the Iowa Pharmacy Board decided to reclassify marijuana as a Schedule II substance, the decision would not necessarily mean the de facto implementation of a medical marijuana law in Iowa. The move would also necessitate legislative and regulatory action.

In the end, however, the entire board voted unanimously to delay the decision until they are scheduled to meet again the first week of January.

Read more

Medical Marijuana||Prohibition

Iowa Board of Pharmacy to Consider the Reclassification of Medical Marijuana

The Iowa Board of Pharmacy is considering renewing its recommendation that the state reclassify marijuana in a way that would make it easier to use the substance legally for medical purposes, following a hearing in the state’s capital yesterday where patients, medical professionals, and drug-abuse prevention specialists testified about whether Iowa should relax its strict ban on the use of medical marijuana.

“We’re in a bit of a predicament,” board Chairman Edward Maier told several dozen people who gathered for the Des Moines hearing, noting that Iowa law currently classifies marijuana as a Schedule I drug.

A similar proposal failed to gain traction in 2009 when the board recommended that state legislators reclassify marijuana as a Schedule II drug, which would make the substance legal with a physician’s recommendation.

Edward Hertko, a retired Des Moines physician and longtime proponent for making marijuana legal, said opponents have falsely characterized marijuana as addictive and as a gateway to harder drugs.

“Its hazards pale when compared with alcohol and tobacco,” he told the pharmacy board. “In fact, marijuana is less deadly than sugar, which causes thousands of deaths each year from obesity and diabetes,” he said.

In addition, Lori Tassin, a cancer patient also from Des Moines, said she believes the substance can shrink tumors and provide other medical benefits.

“It should be my choice,” she told the board. “It should be between my doctor and me.”

The entire Iowa Board of Pharmacy will further discuss the issue Wednesday. Moreover, Maier, a Mapleton pharmacist, noted that the board does not have the authority to make medical marijuana legal. However, he did state that the board could advise Iowa state legislators on the issue.

Read more

Medical Marijuana

Nation’s Largest Medical Association Calls For Review of Marijuana’s Legal Status

Nov 10, 2009 Kate Zawidzki

AMA, Schedule I, Schedule II

Big news: The American Medical Association adopted a new policy position today calling for the review of marijuana’s status as a Schedule I drug.

The revised policy "urges that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines, and alternate delivery methods.” While it goes on to explain that the AMA is not stating support for state medical marijuana laws, the new policy does fall in line with what is quickly becoming a universal understanding in American medicine: Marijuana has undeniable medical uses and federal law should reflect that reality.

The new policy marks a historic shift from the AMA’s previous position, which recommended that “marijuana be retained in Schedule I,” grouping marijuana with drugs such as heroin, LSD, and PCP that are deemed to have no accepted medical uses.

The AMA’s previous position was often cited by medical marijuana opponents as evidence that the drug’s medical efficacy was in question. This new policy will go a long way to convincing politicians and policy makers that the compassionate use of medical marijuana should not be blocked by outdated marijuana laws.

Read more